Nikhil Mehta
Nessuna posizione attualmente
Profilo
Nikhil Mehta worked as Vice President-Global Regulatory Affairs at Merck & Co., Inc. from 2010 to 2015.
He then worked as Chief Regulatory Strategist & Executive VP at Tang Capital Management LLC.
In 2015, he joined Baxalta, Inc. as Global Head-Regulatory Affairs, where he worked until 2016.
From 2017 to 2019, he worked as Senior VP-Regulatory & Quality Assurance at AVEO Pharmaceuticals, Inc. Dr. Mehta holds a doctorate degree from Rutgers State University of New Jersey.
Precedenti posizioni note di Nikhil Mehta
| Società | Posizione | Fine |
|---|---|---|
| AVEO PHARMACEUTICALS, INC. | General Counsel | 08/10/2019 |
| BAXALTA INC | General Counsel | 01/06/2016 |
| MERCK & CO., INC. | General Counsel | 01/01/2015 |
Tang Capital Management LLC
 Tang Capital Management LLC Investment ManagersFinance Tang Capital Management LLC (Tang Capital) is an independent hedge fund manager headquartered in San Diego, California. The firm was founded by Kevin Tang in 2002. Tang Capital provides investment advice to high-net-worth clients. | General Counsel | - |
Formazione di Nikhil Mehta
| Rutgers State University of New Jersey | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Tang Capital Management LLC
Tang Capital Management LLC Investment ManagersFinance Tang Capital Management LLC (Tang Capital) is an independent hedge fund manager headquartered in San Diego, California. The firm was founded by Kevin Tang in 2002. Tang Capital provides investment advice to high-net-worth clients. | Finance |
Baxalta, Inc.
 Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Nikhil Mehta
